Skip to main content

Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma

Enrolling by invitation · Phase 2 · NCT06609239

Conditions: Asthma

At a glance

Research payments reported, 2025
$2.4M
U.S. investigators named
27
Sites paid
28
Planned or actual enrollment
900

About the trial

Sponsor
Sanofi
Tested
Lunsekimig (drug)
Dates
Started 2024-09-30; completion 2031-01-20
Results posted
Not yet

This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma who have previously completed the parent studies. After completion of the parent study, eligible participants will be offered the opportunity to participate in the long-term extension (LTE) study with lunsekimig. The study duration will be up to 148 weeks with a treatment duration being up to 144 weeks.

From ClinicalTrials.gov, last updated 2026-09-21. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Sanofi US Services Inc. reported $2.4M in research payments for this study in 2025 (148 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Ib Miami LLC $581,572
  • Ok Clinical Research LLC $376,729
  • Elligo Health Research Inc $233,394
  • Clintex Research Group Inc $221,095
  • Qway Research Llc $172,887
  • New Access Research and Medical Services Inc $170,345
  • High Quality Research Inc $109,706
  • Metroplex Pulmonary and Sleep Center $70,404
  • University of Michigan Health System, MI $57,905
  • Deluxe Health Center $54,504
  • Western States Clinical Research in $38,018
  • Allianz Research Institute Co Llc $35,555
  • Brigham and Women's Hospital, MA $34,351
  • Beautiful Minds Clinical Research Center $33,097
  • Javara Inc $32,559
  • Howland Allergy Asthma PLLC Orion Clinical Research $31,825
  • Allergy and Clinical Immunology Associates, PC $23,713
  • Baylor College of Medicine Anesthesiology $22,305
  • Toledo Institute of Clinical Resear Inc $20,653
  • Helix Biomedics Llc $17,708
  • Western Sky Medical Research $17,509
  • Midwest Clinical Research Center St Louis $15,615
  • American Carolina Clinical Research $14,953
  • Pines Care Research Center Llc $14,160
  • Sarasota Fl Clinical Research Llc Sarasota Clinical Research $13,195
  • Ricardo Antonio Tan MD Inc $13,195
  • Equity Medical Llc $10,932

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.